High Pretransplantation Soluble CD30 Levels: Impact in Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 8, 2007, Pages 2574-2575

  Giannoli, C ^a   Bonnet, M C ^a   Perrat, G ^a   Houillon, A ^a   Reydet, S ^a   Pouteil Noble, C ^b   Villar, E ^b   Lefrancois N ^c   Morelon, E ^c   Dubois, V ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ANTIGENS, CD; ANTIGENS, CD30; BIOLOGICAL MARKERS; BLOOD DONORS; GRAFT REJECTION; HLA-D ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; REFERENCE VALUES;

EID: 35348961024     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.013     Document Type: Article

References (8)

1. Pelzl S., Opelz G., Wiesel M., et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 73 (2002) 3
2. Süsal C., Pelzl S., Döhler B., et al. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 (2002) 1650
3. Rajakariar R., Jivanji N., Varagunam M., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 5 (2005) 1922
4. Vaidya S., Partlow D., Barnes T., et al. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant 20 (2006) 461
5. Chan K.W., Hopke C.D., Krams S.M., et al. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses. J Immunol 169 (2002) 1784
6. Süsal C., Pelzl S., and Opelz G. Strong human leucocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 76 (2003) 1231
7. Weimer R., Süsal C., Yildiz S., et al. sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. Transplant Proc 37 (2005) 1776
8. Pelzl S., Opelz G., Daniel V., et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75 (2003) 421